Candida dubliniensis is a fungal opportunistic pathogen. Although among the Candida fungi C. albicans seems to be the dominant species among infected people, C. dubliniensis is demanding awareness because of its unique characteristics. C.
dubliniensis has genes which construct it to have resistance against azole drugs such as fluconazole.
Subjects with cancer and other underlying conditions also tested positive for C. dubliniensis, indicating the pathogen mainly targets immunocompromised subjects.